SIK2 expression has been reported to be higher in cancers than in normal tissues surrounding cancer, and reduction in SIK2 expression in OCs showed anti-cancer characteristics including decreased G1/S transition, delayed mitotic progression, and decreased cell survival mechanism by inhibiting Akt activation (70). This evidence concerns the gene SIK2 and cancer.